Clinical Trial Update: A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology

View source ↗

Summary

Clinical trial NCT06043700, sponsored by Eisai Limited, describes a community-based screening program to identify individuals at high risk for amyloid pathology…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Eisai Limited | Conditions: Alzheimer's Disease | Status: ACTIVE_NOT_RECRUITING